✦ LIBER ✦

Safety, tolerability, pharmacokinetics and pharmacodynamics of ascending single and multiple doses of lecozotan in healthy young and elderly subjects

✍ Scribed by Alain Patat; Virginia Parks; Sangeeta Raje; Anna Plotka; Didier Chassard; F. Le Coz

Book ID: 108642244
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 754 KB
Volume: 67
Category: Article
ISSN: 0306-5251
DOI: 10.1111/j.1365-2125.2008.03348.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics, pharmacodynamics, tole

Pharmacokinetics, pharmacodynamics, tolerability and safety of single ascending doses of ticagrelor, a reversibly binding oral P2Y12receptor antagonist, in healthy subjects

✍ Renli Teng; Kathleen Butler 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 224 KB

Safety, tolerability, and pharmacokineti

Safety, tolerability, and pharmacokinetics of single ascending doses of synthetic genistein (Bonistein™) in healthy volunteers

✍ Uwe Ullmann; Juergen Metzner; Thomas Frank; William Cohn; Christoph Riegger 📂 Article 📅 2005 🏛 Springer Healthcare Communications 🌐 English ⚖ 506 KB

Ibudilast in healthy volunteers: safety,

Ibudilast in healthy volunteers: safety, tolerability and pharmacokinetics with single and multiple doses

✍ Paul Rolan; Jacqueline A. Gibbons; Lin He; Eppie Chang; Drew Jones; Matthew I. G 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 761 KB

Pharmacokinetics, safety and tolerance o

Pharmacokinetics, safety and tolerance of single- and multiple-dose adefovir dipivoxil in healthy Chinese subjects

✍ De-qing Sun; Hai-sheng Wang; Mei-yuan Ni; Ben-jie Wang; Rui-chen Guo 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB

Pharmacokinetics and pharmacodynamics of

Pharmacokinetics and pharmacodynamics of single and multiple doses of the MAO-6 inhibitor lazabemide in healthy subjects

✍ Jasper Dingemanse; Nolan Wood; Karin Jorga; Rolf Kettler 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 640 KB

Clinical pharmacokinetics and tolerabili

Clinical pharmacokinetics and tolerability of alpidem in healthy subjects given increasing single doses

✍ J. H. G. Jonkman; G. Bianchetti; G. Grasmeijer; B. Oosterhuis; J. F. Thiercelin; 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 515 KB

In a double-blind, placebo-controlled, cross-over experiment in 21 healthy male volunteers, aged 19 to 27 y, the pharmacokinetics and tolerance of the new anxiolytic drug alpidem (SL80.0342) and its three major metabolites were studied after single doses of 25, 50, 100 and 200 mg. Plasma concentrati